Suchergebnisse - (Person:"Wagner, Kathryn R")

PubPharm (6)

1

Quantitative muscle analysis in facioscapulohumeral muscular dystrophy using whole-body fat-referenced MRI : Protocol development, multicenter feasibility, and repeatability

enthalten in: Muscle & nerve | 2022

von Widholm, P. | Ahlgren, A. | Karlsson, M. | +13

2

Randomized phase 2 study of ACE-083, a muscle-promoting agent, in facioscapulohumeral muscular dystrophy

enthalten in: Muscle & nerve | 2022

von Statland, J. | Campbell, C. | Desai, U. | +26

3

Home-based gait analysis as an exploratory endpoint during a multicenter phase 1 trial in limb girdle muscular dystrophy type R2 and facioscapulohumeral muscular dystrophy

enthalten in: Muscle & nerve | 2022

von Gidaro, T. | Gasnier, E. | Annoussamy, M. | +9

4

Safety, tolerability, and pharmacokinetics of casimersen in patients with Duchenne muscular dystrophy amenable to exon 45 skipping : A randomized, double-blind, placebo-controlled, dose-titration trial

enthalten in: Muscle & nerve | 2021

von Wagner, K. | Kuntz, N. | Koenig, E. | +4

5

A phase Ib/IIa, open-label, multiple ascending-dose trial of domagrozumab in fukutin-related protein limb-girdle muscular dystrophy

enthalten in: Muscle & nerve | 2021

von Leung, D. | Bocchieri, A. | Ahlawat, S. | +10

6

The care of patients with Duchenne, Becker, and other muscular dystrophies in the COVID-19 pandemic

enthalten in: Muscle & nerve | 2020

von Veerapandiyan, A. | Wagner, K. | Apkon, S. | +12

1
[1]